Roberto Mina

17PUBLICATIONS
102CO-AUTHORS
Gene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 27, 2026
Optimizing the Real-World Use of BCMA-Targeted T-Cell-Engaging Therapies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: An Italian Modified Delphi Consensus.

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Apr 06, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

|Jul 17, 2025
Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.

Ola Landgren, Noa Biran, Elizabeth K O'Donnell

|Feb 13, 2025
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts.

Mattia D'Agostino, Marina Martello, Lorenzo De Paoli

|Oct 13, 2021
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.

Carlo Visco, Luigi Marcheselli, Roberto Mina

Pageof 3

Frequent Collaborators

5 joint publications

Francesca M Gay

3 joint publications

Silvia Mangiacavalli

3 joint publications

Renato Zambello

3 joint publications

Elena Zamagni